Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

1.34
+0.11008.94%
Pre-market: 1.360.0185+1.38%07:02 EDT
Volume:2.91M
Turnover:3.83M
Market Cap:21.84M
PE:-0.08
High:1.40
Open:1.18
Low:1.17
Close:1.23
52wk High:45.50
52wk Low:0.8000
Shares:16.30M
Float Shares:15.70M
Volume Ratio:0.38
T/O Rate:18.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.8000
EPS(LYR):-13.1357
ROE:-247.78%
ROA:-30.31%
PB:-0.61
PE(LYR):-0.10

Loading ...

NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM

Reuters
·
Apr 12

Quince Therapeutics trading halted, news pending

TIPRANKS
·
Apr 11

Quince Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 11

Quince FY25 net loss widens 48% to $84 million

Reuters
·
Apr 11

U.S. Earnings Preview: After Market Close April 10

Dow Jones
·
Apr 11

NASD Most Active Issues

Dow Jones
·
Apr 10

NASD Most Active Issues

Dow Jones
·
Apr 08

Quince Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Apr 03

Top News Today/Canada: Goods-Trade Deficit Widens, Surplus With U.S. Narrows

Dow Jones
·
Apr 03

Quince Therapeutics delays annual 10-K filing, cites added time for accounting procedures

Reuters
·
Apr 02

NASD Most Active Issues

Dow Jones
·
Mar 31

BRIEF-Quince Therapeutics Settles Approximately $16.4 Million Of Debt

Reuters
·
Mar 30

Quince Therapeutics - Settles Eib Loan Obligations for $5.5 Mln - SEC Filing

THOMSON REUTERS
·
Mar 30

Quince Therapeutics settles $16 million EIB debt in restructuring milestone

Reuters
·
Mar 30

Quince Therapeutics Settles Approximately $16.4 Million of Debt

THOMSON REUTERS
·
Mar 30

U.S. Earnings Preview: After Market Close March 27

Dow Jones
·
Mar 28

Nasdaq flags Quince Therapeutics for sub-$1 bid price and sub-USD 50 million market value

Reuters
·
Mar 21

U.S. Earnings Preview: After Market Close March 20

Dow Jones
·
Mar 21

Quince Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
Mar 20

NASD Most Active Issues

Dow Jones
·
Mar 12